- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| SCIBASE Aktie jetzt für 0€ handeln | |||||
| Fr | SciBase: New study shows significant improved clinical accuracy with Nevisense for both US and German dermatologists | 202 | PR Newswire | STOCKHOLM, Feb. 21, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders announced today, that... ► Artikel lesen | |
| 30.01. | SciBase continues US expansion, on-boards Several US Dermatology Practices that Specialize in Skin Cancer Detection | 165 | PR Newswire | STOCKHOLM, Jan. 30, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders announced today that... ► Artikel lesen | |
| 28.01. | SciBase: New review article highlights Nevisense effectiveness in identifying malignant skin lesions | 222 | PR Newswire | STOCKHOLM, Jan. 28, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders announced today that... ► Artikel lesen | |
| 27.01. | SciBase: Recalculation of warrants of series TO 2 following rights issue | 267 | PR Newswire | STOCKHOLM, Jan. 27, 2025 /PRNewswire/ -- In accordance with the terms and conditions for warrants of series TO 2, which were issued in connection with the capital raise announced in April... ► Artikel lesen | |
| 23.01. | SciBase: Nevisense (EIS) included in updated German (S1) imaging guidelines | 310 | PR Newswire | STOCKHOLM, Sweden, Jan. 23, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") [STO:SCIB], a leading developer of augmented intelligence-based solutions for skin disorders, announced today... ► Artikel lesen | |
| 23.01. | SCIBASE: Nevisense (EIS) included in updated German (S1) imaging guidelines. | 2 | Cision News | ||
| 14.01. | SciBase announces final outcome of directed issue and rights issue | 305 | PR Newswire | STOCKHOLM, Jan. 14, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase" or the "Company") today announces the final outcome of the capital raise, consisting of a rights issue of units of approximately... ► Artikel lesen | |
| 13.01. | SciBase announces outcome of directed issue and preliminary outcome of rights issue | 293 | PR Newswire | STOCKHOLM, Jan. 13, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase" or the "Company") today announces the preliminary outcome of the capital raise, consisting of a rights issue of units... ► Artikel lesen | |
| 03.01. | SciBase: The Mayo Clinic, the leading US hospital, will test Nevisense in Pilot | 357 | PR Newswire | STOCKHOLM, Jan. 3, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders, announced today that... ► Artikel lesen | |
| 27.12.24 | Today the subscription period in SciBase rights issue begins | 494 | PR Newswire | STOCKHOLM, Dec. 27, 2024 /PRNewswire/ -- Today, on December 27, 2024, is the first day of the subscription period in SciBase Holding AB's ("SciBase" or the "Company") rights issue of units... ► Artikel lesen | |
| 20.12.24 | SciBase letter from the CEO | 388 | PR Newswire | STOCKHOLM, Dec. 20, 2024 /PRNewswire/ -- In 2024, SciBase has advanced its positions significantly and laid the foundation for continued growth, with a new organization in the US, success... ► Artikel lesen | |
| 20.12.24 | SciBase publishes prospectus | 397 | PR Newswire | STOCKHOLM, Dec. 20, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase" or the "Company") announced on November 12, 2024 that the Board of Directors has resolved, subject to the subsequent... ► Artikel lesen | |
| 18.12.24 | XFRA CAPITAL ADJUSTMENT INFORMATION - 18.12.2024 | 310 | Xetra Newsboard | Das Instrument 087 GB00BD7XPJ64 NEWRIVER REIT LS-,01 EQUITY wird cum Kapitalmassnahme gehandelt am 18.12.2024 und ex Kapitalmassnahme am 19.12.2024 The instrument 087 GB00BD7XPJ64 NEWRIVER REIT LS-... ► Artikel lesen | |
| 13.12.24 | Bulletin from the extraordinary general meeting in SciBase Holding AB (publ) | 395 | PR Newswire | STOCKHOLM, Dec. 13, 2024 /PRNewswire/ -- Today, an extraordinary general meeting has been held in SciBase Holding AB (publ) ("SciBase" or the "Company"). The general meeting resolved in accordance... ► Artikel lesen | |
| 13.11.24 | SciBase Announces Positive Findings in Case Study Monitoring Treatment Outcomes in Atopic Dermatitis Patient | 414 | PR Newswire | STOCKHOLM, Nov. 13, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of artificial intelligence (AI)-based solutions for skin is excited to announce the... ► Artikel lesen | |
| 12.11.24 | Notice to extraordinary general meeting in Scibase Holding AB (publ) | 271 | PR Newswire | STOCKHOLM, Nov. 12, 2024 /PRNewswire/ -- Shareholders of SciBase Holding AB (publ), reg. no. 556773-4768 (the "Company"), are hereby summoned to an extraordinary general meeting to be held... ► Artikel lesen | |
| 12.11.24 | SciBase announces collaboration for prediction of atopic dermatitis in infants | 375 | PR Newswire | STOCKHOLM, Nov. 12, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders, announced today its... ► Artikel lesen | |
| 12.11.24 | SciBase decides on a directed issue of approximately SEK 22.5 million and a rights issue of up to approximately SEK 59.3 million | 500 | PR Newswire | STOCKHOLM, Nov. 12, 2024 /PRNewswire/ -- The Board of Directors of SciBase Holding AB (publ) ("SciBase" or the "Company") has today decided to carry out a capital raise totaling approximately... ► Artikel lesen | |
| 12.11.24 | SciBase: Interim report January 1 - September 30, 2024 | 273 | PR Newswire | STOCKHOLM, Nov. 12, 2024 /PRNewswire/ -- January 1 - September 30, 2024
The third quarter in figures
Net sales were TSEK 8,408 (7,248), +16%.The loss after tax was TSEK 17,753... ► Artikel lesen | |
| 30.10.24 | SciBase initiates sales collaboration in Italy | 221 | PR Newswire | STOCKHOLM, Oct. 30, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders announces today the collaboration... ► Artikel lesen |
Seite:
1 2 3 Weiter >>
56 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ROKU | 85,20 | +0,27 % | Streaming-Revolution?: Roku-Rallye: Analysten heben Kursziele drastisch an! | © Foto: Pavlo Gonchar - picture allianceDie Kursziele von Roku wurden angehoben, da Analysten großes Wachstumspotenzial sehen - steckt hier die nächste große Investmentchance?Die Aktie von Roku verzeichnete... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,138 | +3,75 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 13.02.2025 | Das Instrument PSH0 CA81752F1062 SERNOVA BIOTHERAPEUTICS EQUITY hat seinen ersten Handelstag am 13.02.2025: CONTINUOUS TRADING WITH AUCTIONS, PAG NAM0, SettlCurr EUR, CCP Y
The instrument PSH0 CA81752F1062... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 100,00 | 0,00 % | Boston Scientific's American Medical Systems Europe Prices EUR 1.5 Bln Of Senior Notes | WASHINGTON (dpa-AFX) - Boston Scientific Corp. (BSX) announced that American Medical Systems Europe B.V., its wholly owned finance subsidiary, has priced a public offering of 850 million euros... ► Artikel lesen | |
| PAUL HARTMANN | 239,00 | 0,00 % | Vorläufiges Jahresergebnis 2024: PAUL HARTMANN steigert Ergebnis gegenüber dem Vorjahr deutlich und strebt für 2025 weitere Verbesserung an | Heidenheim (ots) - HARTMANN hat im vergangenen Jahr sein Transformationsprogramm erfolgreich weitergeführt. Es trug zu deutlichen Verbesserungen im Ergebnis bei, trotz konstant herausfordernder Marktlage.... ► Artikel lesen | |
| ADDLIFE | 15,050 | +0,94 % | AddLife AB: Year-end Report 1 January - 31 December 2024 | AddLife finishes the year with high growth, improved margins, and strong cash flow
"AddLife finishes 2024 with a very strong fourth quarter. Organic growth was 9%, EBITA increased by 24%, and cash... ► Artikel lesen | |
| EMBECTA | 13,700 | -5,52 % | Embecta Corp. Reports First Quarter Fiscal 2025 Financial Results | PARSIPPANY, N.J., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta" or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three month... ► Artikel lesen | |
| R1 RCM | 13,400 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 19.11.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 19.11.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 19.11.2024ISIN NameAU000000SVW5 SEVEN... ► Artikel lesen | |
| ENOVIS | 41,000 | 0,00 % | Enovis Corporation: Enovis Announces Leadership Change to International Surgical Business | Wilmington, DE, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Enovis, a global medical technology innovator headquartered in the United States, announced recently that Davide Visentin will succeed Dr. Benjamin... ► Artikel lesen | |
| SYSMEX | 17,100 | 0,00 % | Dividendenbekanntmachungen (27.09.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABRDN EUROPEAN LOGISTICS INCOME PLC GB00BD9PXH49 0,0077 GBP EUR ACADIAN TIMBER CORP CA0042721005 0,29 CAD 0,1926 EUR ACOM CO LTD JP3108600002 7... ► Artikel lesen | |
| PULMONX | 7,850 | -8,72 % | Pulmonx Corporation: Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial Results | REDWOOD CITY, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported... ► Artikel lesen | |
| KANGJI MEDICAL | 0,785 | -0,63 % | KANGJI MEDICAL (09997): NEXT DAY DISCLOSURE RETURN | ||
| KOOTH | 1,800 | -1,10 % | TRADING UPDATES: Kooth eyes top-end profit, while IQE sees sales beat | ||
| SI-BONE | 17,100 | 0,00 % | SI-BONE, Inc.: SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2024 | Fourth Quarter 2024 worldwide revenue of ~$48.8 to $49.0 million representing growth of ~26%Achieved adjusted EBITDA profitability in the fourth quarter SANTA CLARA, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE)... ► Artikel lesen | |
| REVITALIST LIFESTYLE AND WELLNESS | 0,015 | 0,00 % | Revitalist Lifestyle & Wellness Ltd: Revitalist Announces Filing of Audited Financial Statements for the Year-Ended December 31, 2022 and Provides Update on Cease Trade Order | Vancouver, British Columbia--(Newsfile Corp. - February 18, 2025) - Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO) (the "Company") wishes to announce that, further to... ► Artikel lesen |
Das Unternehmen SCIBASE HOLDING AB kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -9,09 % bei einem Aktienkurs von 0,008 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SCIBASE HOLDING AB finden Sie auf Wallstreet Online.
